BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15352030)

  • 1. Enhanced cathepsin L expression is mediated by different Ras effector pathways in fibroblasts and epithelial cells.
    Collette J; Ulku AS; Der CJ; Jones A; Erickson AH
    Int J Cancer; 2004 Nov; 112(2):190-9. PubMed ID: 15352030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
    Ulkü AS; Schäfer R; Der CJ
    Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.
    Lucas L; Penalva V; Ramírez de Molina A; Del Peso L; Lacal JC
    Int J Oncol; 2002 Sep; 21(3):477-85. PubMed ID: 12168089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells.
    Pruitt K; Ulkü AS; Frantz K; Rojas RJ; Muniz-Medina VM; Rangnekar VM; Der CJ; Shields JM
    J Biol Chem; 2005 Jun; 280(24):23363-70. PubMed ID: 15831492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways.
    Grana TM; Rusyn EV; Zhou H; Sartor CI; Cox AD
    Cancer Res; 2002 Jul; 62(14):4142-50. PubMed ID: 12124353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.
    Fehrenbacher N; Bastholm L; Kirkegaard-Sørensen T; Rafn B; Bøttzauw T; Nielsen C; Weber E; Shirasawa S; Kallunki T; Jäättelä M
    Cancer Res; 2008 Aug; 68(16):6623-33. PubMed ID: 18701486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose controls cathepsin expression in Ras-transformed fibroblasts.
    Tournu C; Obled A; Roux MP; Deval C; Ferrara M; Béchet DM
    Arch Biochem Biophys; 1998 Dec; 360(1):15-24. PubMed ID: 9826424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization to the lysosomal cell death pathway upon immortalization and transformation.
    Fehrenbacher N; Gyrd-Hansen M; Poulsen B; Felbor U; Kallunki T; Boes M; Weber E; Leist M; Jäättelä M
    Cancer Res; 2004 Aug; 64(15):5301-10. PubMed ID: 15289336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase.
    McFall A; Ulkü A; Lambert QT; Kusa A; Rogers-Graham K; Der CJ
    Mol Cell Biol; 2001 Aug; 21(16):5488-99. PubMed ID: 11463831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways.
    Ward Y; Wang W; Woodhouse E; Linnoila I; Liotta L; Kelly K
    Mol Cell Biol; 2001 Sep; 21(17):5958-69. PubMed ID: 11486034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras-mediated intestinal epithelial cell transformation requires cyclooxygenase-2-induced prostaglandin E2 signaling.
    Repasky GA; Zhou Y; Morita S; Der CJ
    Mol Carcinog; 2007 Dec; 46(12):958-70. PubMed ID: 17477350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin L increased level upon Ras mutants expression: the role of p38 and p44/42 MAPK signaling pathways.
    Urbanelli L; Trivelli F; Ercolani L; Sementino E; Magini A; Tancini B; Franceschini R; Emiliani C
    Mol Cell Biochem; 2010 Oct; 343(1-2):49-57. PubMed ID: 20524145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the Ral and phosphatidylinositol 3' kinase signaling pathways by the ras-related protein TC21.
    Rosário M; Paterson HF; Marshall CJ
    Mol Cell Biol; 2001 Jun; 21(11):3750-62. PubMed ID: 11340168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras, but not Src, transformation of RIE-1 epithelial cells is dependent on activation of the mitogen-activated protein kinase cascade.
    Oldham SM; Cox AD; Reynolds ER; Sizemore NS; Coffey RJ; Der CJ
    Oncogene; 1998 May; 16(20):2565-73. PubMed ID: 9632133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.
    Janda E; Lehmann K; Killisch I; Jechlinger M; Herzig M; Downward J; Beug H; Grünert S
    J Cell Biol; 2002 Jan; 156(2):299-313. PubMed ID: 11790801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Ras signaling specificity by protein kinase C.
    Rusanescu G; Gotoh T; Tian X; Feig LA
    Mol Cell Biol; 2001 Apr; 21(8):2650-8. PubMed ID: 11283245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolytic enzymes at various stages of oncogenic transformation of rat fibroblasts. I. Aspartyl and cysteine proteinases.
    Solovyeva NI; Balayevskaya TO; Dilakyan EA; Zakamaldina-Zama TA; Pozdnev VF; Topol LZ; Kisseljov FL
    Int J Cancer; 1995 Feb; 60(4):495-500. PubMed ID: 7829263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation.
    Oberst MD; Beberman SJ; Zhao L; Yin JJ; Ward Y; Kelly K
    BMC Cancer; 2008 Jul; 8():189. PubMed ID: 18597688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.